These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 8934931)

  • 1. Cellular interactions in the lpr and gld models of systemic autoimmunity.
    Sobel ES
    Adv Dent Res; 1996 Apr; 10(1):76-80. PubMed ID: 8934931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-infusion of normal bone marrow partially corrects the gld T-cell defect. Evidence for an intrinsic and extrinsic role for Fas ligand.
    Sobel ES; Kakkanaiah VN; Kakkanaiah M; Cohen PL; Eisenberg RA
    J Immunol; 1995 Jan; 154(1):459-64. PubMed ID: 7527822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity in mice bearing lprcg: a novel mutant gene.
    Kimura M; Matsuzawa A
    Int Rev Immunol; 1994; 11(3):193-210. PubMed ID: 7930845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional distinctions between MRL-lpr and MRL-gld lymphocytes. Normal cells reverse the gld but not lpr immunoregulatory defect.
    Ettinger R; Wang JK; Bossu P; Papas K; Sidman CL; Abbas AK; Marshak-Rothstein A
    J Immunol; 1994 Feb; 152(4):1557-68. PubMed ID: 8120369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice.
    Reap EA; Leslie D; Abrahams M; Eisenberg RA; Cohen PL
    J Immunol; 1995 Jan; 154(2):936-43. PubMed ID: 7529292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of gld autoimmunity by co-infusion of normal bone marrow suggests that gld is a mutation of the Fas ligand gene.
    Sobel ES; Kakkanaiah VN; Cohen PL; Eisenberg RA
    Int Immunol; 1993 Oct; 5(10):1275-8. PubMed ID: 7505611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor: a lesson from the mouse model.
    Nagata S
    J Hum Genet; 1998; 43(1):2-8. PubMed ID: 9609991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ectopic expression of B7-1 (CD80) on T lymphocytes in autoimmune lpr and gld mice.
    Weintraub JP; Cohen PL
    Clin Immunol; 1999 Jun; 91(3):302-9. PubMed ID: 10370375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological and pathological consequences of mutations in both Fas and Fas ligand.
    Weintraub JP; Godfrey V; Wolthusen PA; Cheek RL; Eisenberg RA; Cohen PL
    Cell Immunol; 1998 May; 186(1):8-17. PubMed ID: 9637760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lpr and gld genes in systemic autoimmunity: life and death in the Fas lane.
    Cohen PL; Eisenberg RA
    Immunol Today; 1992 Nov; 13(11):427-8. PubMed ID: 1282318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific intercellular pathway of apoptotic cell death is defective in the mature peripheral T cells of autoimmune lpr and gld mice.
    Gillette-Ferguson I; Sidman CL
    Eur J Immunol; 1994 May; 24(5):1181-5. PubMed ID: 8181528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic treatment of C3H-lpr/lpr and C3H-gld/gld mice with anti-CD8 monoclonal antibody prevents the accumulation of double negative T cells but not autoantibody production.
    Giese T; Davidson WF
    J Immunol; 1994 Feb; 152(4):2000-10. PubMed ID: 8120404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gld mutation of Fas ligand increases the frequency and up-regulates cell survival genes in CD25+CD4+ TR cells.
    Mohamood AS; Trujillo CJ; Zheng D; Jie C; Murillo FM; Schneck JP; Hamad AR
    Int Immunol; 2006 Aug; 18(8):1265-77. PubMed ID: 16769751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. gld/gld mice are unable to express a functional ligand for Fas.
    Ramsdell F; Seaman MS; Miller RE; Tough TW; Alderson MR; Lynch DH
    Eur J Immunol; 1994 Apr; 24(4):928-33. PubMed ID: 7512035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fas system-mediated apoptosis suppresses lymphopoiesis.
    Yasutomo K; Nagasawa H; Hisaeda H; Good RA; Kuroda Y; Himeno K
    J Immunol; 1996 Sep; 157(5):1981-6. PubMed ID: 8757318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease.
    Cohen PL; Eisenberg RA
    Annu Rev Immunol; 1991; 9():243-69. PubMed ID: 1910678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders.
    Watanabe D; Suda T; Hashimoto H; Nagata S
    EMBO J; 1995 Jan; 14(1):12-8. PubMed ID: 7530197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences defined by bone marrow transplantation suggest that lpr and gld are mutations of genes encoding an interacting pair of molecules.
    Allen RD; Marshall JD; Roths JB; Sidman CL
    J Exp Med; 1990 Nov; 172(5):1367-75. PubMed ID: 2230649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.